Cyclic AMP dynamics in the pancreatic β-cell

References

• Pørksen N. The in vivo regulation of pulsatile insulin secretion. Diabetologia. 2002;45:3–20.
   PubMedGoogle Scholar
• Hellman B. Pulsatility of insulin release—a clinically important phenomenon. Ups J Med Sci. 2009;114:193–205.
   PubMed Web of Science ®Google Scholar
• Schmitz O, Rungby J, Edge L, Juhl CB. On high-frequency insulin oscillations. Ageing Res Rev. 2008;7:301–5.
   PubMed Web of Science ®Google Scholar
• Tengholm A, Gylfe E. Oscillatory control of insulin secretion. Mol Cell Endocrinol. 2009;297:58–72.
   PubMed Web of Science ®Google Scholar
• Gilon P, Ravier MA, Jonas JC, Henquin JC. Control mechanisms of the oscillations of insulin secretion in vitro and in vivo. Diabetes. 2002;51:S144–51.
   PubMed Web of Science ®Google Scholar
• Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic β-cell. Prog Biophys Mol Biol. 1989;54:87–143.
   PubMed Web of Science ®Google Scholar
• Henquin JC. Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia. 2009;52:739–51.
   PubMed Web of Science ®Google Scholar
• Bertram R, Sherman A, Satin LS. Metabolic and electrical oscillations: partners in controlling pulsatile insulin secretion. Am J Physiol Endocrinol Metab. 2007;293:E890–900.
   PubMed Web of Science ®Google Scholar
• Kennedy RT, Kauri LM, Dahlgren GM, Jung SK. Metabolic oscillations in β-cells. Diabetes. 2002;51:S152–61.
   PubMedGoogle Scholar
• Samols E, Marri G, Marks V. Promotion of insulin secretion by glucagon. Lancet. 1965;2:415–16.
   PubMed Web of Science ®Google Scholar
• Sussman KE, Vaughan GD. Insulin release after ACTH, glucagon and adenosine-3'-5'-phosphate (cyclic AMP) in the perfused isolated rat pancreas. Diabetes. 1967;16:449–54.
   PubMed Web of Science ®Google Scholar
• Malaisse WJ, Malaisse-Lagae F, Mayhew D. A possible role for the adenylcyclase system in insulin secretion. J Clin Invest. 1967;46:1724–34.
   PubMed Web of Science ®Google Scholar
• Turtle JR, Littleton GK, Kipnis DM. Stimulation of insulin secretion by theophylline. Nature. 1967;213:727–8.
   PubMed Web of Science ®Google Scholar
• Turtle JR, Kipnis DM. An adrenergic receptor mechanism for the control of cyclic 3'5' adenosine monophosphate synthesis in tissues. Biochem Biophys Res Commun. 1967;28:797–802.
   PubMed Web of Science ®Google Scholar
• Seino S, Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol Rev. 2005;85:1303–42.
   PubMed Web of Science ®Google Scholar
• Furman B, Ong WK, Pyne NJ. Cyclic AMP signaling in pancreatic islets. Adv Exp Med Biol. 2010;654:281–304.
   PubMed Web of Science ®Google Scholar
• Altarejos JY, Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol. 2011;12:141–51.
   PubMed Web of Science ®Google Scholar
• Holz GG 4th, Kuhtreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7–37). Nature. 1993;361:362–5.
   PubMed Web of Science ®Google Scholar
• Schuit FC. Factors determining the glucose sensitivity and glucose responsiveness of pancreatic beta cells. Horm Res. 1996;46:99–106.
   PubMedGoogle Scholar
• Fujimoto W, Miki T, Ogura T, Zhang M, Seino Y, Satin LS, Niflumic acid-sensitive ion channels play an important role in the induction of glucose-stimulated insulin secretion by cyclic AMP in mice. Diabetologia. 2009;52:863–72.
   PubMedGoogle Scholar
• Gloerich M, Bos JL. Epac: defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol. 2010;50:355–75.
   PubMed Web of Science ®Google Scholar
• Willoughby D, Cooper DM. Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains. Physiol Rev. 2007;87:965–1010.
   PubMed Web of Science ®Google Scholar
• Leech CA, Castonguay MA, Habener JF. Expression of adenylyl cyclase subtypes in pancreatic β-cells. Biochem Biophys Res Commun. 1999;254:703–6.
   PubMedGoogle Scholar
• Guenifi A, Portela-Gomes GM, Grimelius L, Efendic S, Abdel-Halim SM. Adenylyl cyclase isoform expression in non-diabetic and diabetic Goto-Kakizaki (GK) rat pancreas. Evidence for distinct overexpression of type-8 adenylyl cyclase in diabetic GK rat islets. Histochem Cell Biol. 2000;113:81–9.
   PubMedGoogle Scholar
• Delmeire D, Flamez D, Hinke SA, Cali JJ, Pipeleers D, Schuit F. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1. Diabetologia. 2003;46:1383–93.
   PubMed Web of Science ®Google Scholar
• Charles MA, Lawecki J, Pictet R, Grodsky GM. Insulin secretion. Interrelationships of glucose, cyclic adenosine 3:5-monophosphate, and calcium. J Biol Chem. 1975;250:6134–40.
   PubMed Web of Science ®Google Scholar
• Valverde I, Vandermeers A, Anjaneyulu R, Malaisse WJ. Calmodulin activation of adenylate cyclase in pancreatic islets. Science. 1979;206:225–7.
   PubMed Web of Science ®Google Scholar
• Sharp GW, Wiedenkeller DE, Kaelin D, Siegel EG, Wollheim CB. Stimulation of adenylate cyclase by Ca2+ and calmodulin in rat islets of Langerhans: explanation for the glucose-induced increase in cyclic AMP levels. Diabetes. 1980;29:74–7.
   PubMed Web of Science ®Google Scholar
• Roger B, Papin J, Vacher P, Raoux M, Mulot A, Dubois M, Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells. Diabetologia. 2011;54:390–402.
   PubMed Web of Science ®Google Scholar
• Willoughby D, Everett KL, Halls ML, Pacheco J, Skroblin P, Vaca L, Direct binding between Orai1 and AC8 mediates dynamic interplay between Ca2+ and cAMP signaling. Sci Signal. 2012;5:ra29.
   Google Scholar
• Martin AC, Willoughby D, Ciruela A, Ayling LJ, Pagano M, Wachten S, Capacitative Ca2+ entry via Orai1 and stromal interacting molecule 1 (STIM1) regulates adenylyl cyclase type 8. Mol Pharmacol. 2009;75:830–42.
   PubMedGoogle Scholar
• Willoughby D, Masada N, Wachten S, Pagano M, Halls ML, Everett KL, AKAP79/150 interacts with AC8 and regulates Ca2+-dependent cAMP synthesis in pancreatic and neuronal systems. J Biol Chem. 2010;285:20328–42.
   PubMedGoogle Scholar
• Liu YJ, Gylfe E. Store-operated Ca2+ entry in insulin-releasing pancreatic β-cells. Cell Calcium. 1997;22:277–86.
   PubMed Web of Science ®Google Scholar
• Tian Y, Laychock SG. Protein kinase C and calcium regulation of adenylyl cyclase in isolated rat pancreatic islets. Diabetes. 2001;50:2505–13.
   PubMedGoogle Scholar
• Thams P, Capito K, Hedeskov CJ. Stimulation by glucose of cyclic AMP accumulation in mouse pancreatic islets is mediated by protein kinase C. Biochem J. 1988;253:229–34.
   PubMedGoogle Scholar
• Bozem M, Nenquin M, Henquin JC. The ionic, electrical, and secretory effects of protein kinase C activation in mouse pancreatic B-cells: studies with a phorbol ester. Endocrinology. 1987;121:1025–33.
   PubMedGoogle Scholar
• Dyachok O, Idevall-Hagren O, Sågetorp J, Tian G, Wuttke A, Arrieumerlou C, Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion. Cell Metab. 2008;8:26–37.
   PubMedGoogle Scholar
• Ramos LS, Zippin JH, Kamenetsky M, Buck J, Levin LR. Glucose and GLP-1 stimulate cAMP production via distinct adenylyl cyclases in INS-1E insulinoma cells. J Gen Physiol. 2008;132:329–38.
   PubMed Web of Science ®Google Scholar
• Chen Y, Cann MJ, Litvin TN, Iourgenko V, Sinclair ML, Levin LR, Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. Science. 2000;289:625–8.
   PubMed Web of Science ®Google Scholar
• Litvin TN, Kamenetsky M, Zarifyan A, Buck J, Levin LR. Kinetic properties of “soluble” adenylyl cyclase. Synergism between calcium and bicarbonate. J Biol Chem. 2003;278:15922–6.
   PubMed Web of Science ®Google Scholar
• Jaiswal BS, Conti M. Calcium regulation of the soluble adenylyl cyclase expressed in mammalian spermatozoa. Proc Natl Acad Sci USA. 2003;100:10676–81.
   PubMedGoogle Scholar
• Tian G, Sandler S, Gylfe E, Tengholm A. Glucose- and hormone-induced cAMP oscillations in α- and β-cells within intact pancreatic islets. Diabetes. 2011;60:1535–43.
   PubMed Web of Science ®Google Scholar
• Conti M, Beavo J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem. 2007;76:481–511.
   PubMed Web of Science ®Google Scholar
• Pyne NJ, Furman BL. Cyclic nucleotide phosphodiesterases in pancreatic islets. Diabetologia. 2003;46:1179–89.
   PubMed Web of Science ®Google Scholar
• Degerman E, Ahmad F, Chung YW, Guirguis E, Omar B, Stenson L, From PDE3B to the regulation of energy homeostasis. Curr Opin Pharmacol. 2011;11:676–82.
   PubMed Web of Science ®Google Scholar
• Sugden MC, Ashcroft SJ. Cyclic nucleotide phosphodiesterase of rat pancreatic islets. Effects of Ca2+, calmodulin and trifluoperazine. Biochem J. 1981;197:459–64.
   PubMed Web of Science ®Google Scholar
• Lipson LG, Oldham SB. The role of calmodulin in insulin secretion: the presence of a calmodulin-stimulatable phosphodiesterase in pancreatic islets of normal and pregnant rats. Life Sci. 1983;32:775–80.
   PubMed Web of Science ®Google Scholar
• Capito K, Hedeskov CJ, Thams P. Cyclic AMP phosphodiesterase activity in mouse pancreatic islets. Effects of calmodulin and phospholipids. Acta Endocrinol (Copenh). 1986;111:533–8.
   PubMedGoogle Scholar
• Han P, Werber J, Surana M, Fleischer N, Michaeli T. The calcium/calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion. J Biol Chem. 1999;274:22337–44.
   PubMedGoogle Scholar
• Dov A, Abramovitch E, Warwar N, Nesher R. Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose. Endocrinology. 2008;149:741–8.
   PubMedGoogle Scholar
• Waddleton D, Wu W, Feng Y, Thompson C, Wu M, Zhou YP, Phosphodiesterase 3 and 4 comprise the major cAMP metabolizing enzymes responsible for insulin secretion in INS-1 (832/13) cells and rat islets. Biochem Pharmacol. 2008;76:884–93.
   PubMed Web of Science ®Google Scholar
• Parker JC, VanVolkenburg MA, Ketchum RJ, Brayman KL, Andrews KM. Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion. Biochem Biophys Res Commun. 1995;217:916–23.
   PubMed Web of Science ®Google Scholar
• Heimann E, Jones HA, Resjö S, Manganiello VC, Stenson L, Degerman E. Expression and regulation of cyclic nucleotide phosphodiesterases in human and rat pancreatic islets. PLoS One. 2010;5:e14191.
   Google Scholar
• Härndahl L, Jing XJ, Ivarsson R, Degerman E, Ahren B, Manganiello VC, Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic β-cell exocytosis and release of insulin. J Biol Chem. 2002;277:37446–55.
   PubMedGoogle Scholar
• Härndahl L, Wierup N, Enerbäck S, Mulder H, Manganiello VC, Sundler F, β-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology. J Biol Chem. 2004;279:15214–22.
   PubMedGoogle Scholar
• Zhao AZ, Zhao H, Teague J, Fujimoto W, Beavo JA. Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B. Proc Natl Acad Sci USA. 1997;94:3223–8.
   PubMedGoogle Scholar
• Choi YH, Park S, Hockman S, Zmuda-Trzebiatowska E, Svennelid F, Haluzik M, Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice. J Clin Invest. 2006;116:3240–51.
   PubMed Web of Science ®Google Scholar
• Walz HA, Wierup N, Vikman J, Manganiello VC, Degerman E, Eliasson L, β-cell PDE3B regulates Ca2+-stimulated exocytosis of insulin. Cell Signal. 2007;19:1505–13.
   PubMedGoogle Scholar
• Shafiee-Nick R, Pyne NJ, Furman BL. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity. Br J Pharmacol. 1995;115:1486–92.
   PubMedGoogle Scholar
• Cantin LD, Magnuson S, Gunn D, Barucci N, Breuhaus M, Bullock WH, PDE-10A inhibitors as insulin secretagogues. Bioorg Med Chem Lett. 2007;17:2869–73.
   PubMedGoogle Scholar
• Tian G, Sågetorp J, Xu Y, Shuai H, Degerman E, Tengholm A. Role of phosphodiesterases in the shaping of sub-plasma membrane cAMP oscillations and pulsatile insulin secretion. J Cell Sci. 2012; in press, doi:10.1242/jcs.107201.
   Google Scholar
• Drucker DJ. The biology of incretin hormones. Cell Metab. 2006;3:153–65.
   PubMed Web of Science ®Google Scholar
• Filipsson K, Kvist-Reimer M, Ahren B. The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function. Diabetes. 2001;50:1959–69.
   PubMed Web of Science ®Google Scholar
• Al-Majed HT, Jones PM, Persaud SJ, Sugden D, Huang GC, Amiel S, ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of Langerhans. J Endocrinol. 2004;180:155–66.
   PubMedGoogle Scholar
• Sharp GW. Mechanisms of inhibition of insulin release. Am J Physiol. 1996;271:C1781–99.
   PubMedGoogle Scholar
• Dezaki K, Damdindorj B, Sone H, Dyachok O, Tengholm A, Gylfe E, Ghrelin attenuates cAMP-PKA signaling to evoke insulinostatic cascade in islet β-cells. Diabetes. 2011;60:2315–24.
   PubMedGoogle Scholar
• Renström E, Ding WG, Bokvist K, Rorsman P. Neurotransmitter-induced inhibition of exocytosis in insulin-secreting β cells by activation of calcineurin. Neuron. 1996;17:513–22.
   PubMedGoogle Scholar
• Peschke E, Mühlbauer E. New evidence for a role of melatonin in glucose regulation. Best Pract Res Clin Endocrinol Metab. 2010;24:829–41.
   PubMed Web of Science ®Google Scholar
• Dyachok O, Isakov Y, Sågetorp J, Tengholm A. Oscillations of cyclic AMP in hormone-stimulated insulin-secreting β-cells. Nature. 2006;439:349–52.
   PubMed Web of Science ®Google Scholar
• Takeda Y, Amano A, Noma A, Nakamura Y, Fujimoto S, Inagaki N. Systems analysis of GLP-1 receptor signaling in pancreatic β-cells. Am J Physiol Cell Physiol. 2011;301:C792–803.
   Google Scholar
• Fridlyand LE, Harbeck MC, Roe MW, Philipson LH. Regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic β-cell: a computational approach. Am J Physiol Cell Physiol. 2007;293:C1924–33.
   PubMedGoogle Scholar
• Ravier MA, Guldenagel M, Charollais A, Gjinovci A, Caille D, Sohl G, Loss of connexin36 channels alters b-cell coupling, islet synchronization of glucose-induced Ca2+ and insulin oscillations, and basal insulin release. Diabetes. 2005;54:1798–807.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Galvanovskis J, Abdulkader F, Partridge CJ, Göpel SO, Eliasson L, Cell coupling in mouse pancreatic β-cells measured in intact islets of Langerhans. Philos Transact A Math Phys Eng Sci. 2008;366:3503–23.
   PubMed Web of Science ®Google Scholar
• Grill V, Cerasi E. Activation by glucose of adenyl cyclase in pancreatic islets of the rat. FEBS Lett. 1973;33:311–14.
   PubMed Web of Science ®Google Scholar
• Sharp GW. The adenylate cyclase-cyclic AMP system in islets of Langerhans and its role in the control of insulin release. Diabetologia. 1979;16:287–96.
   PubMed Web of Science ®Google Scholar
• Hellman B, Idahl LÅ, Lernmark Å, Täljedal IB. The pancreatic b-cell recognition of insulin secretagogues: does cyclic AMP mediate the effect of glucose? Proc Natl Acad Sci USA. 1974;71:3405–9.
   PubMed Web of Science ®Google Scholar
• Pipeleers DG, Schuit FC, in't Veld PA, Maes E, Hooghe-Peters EL, Van de Winkel M, Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology. 1985;117:824–33.
   PubMed Web of Science ®Google Scholar
• Schuit FC, Pipeleers DG. Regulation of adenosine 3',5'-monophosphate levels in the pancreatic B cell. Endocrinology. 1985;117:834–40.
   PubMed Web of Science ®Google Scholar
• Landa LR Jr, Harbeck M, Kaihara K, Chepurny O, Kitiphongspattana K, Graf O, Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 β-cell line. J Biol Chem. 2005;280:31294–302.
   PubMed Web of Science ®Google Scholar
• Ni Q, Ganesan A, Aye-Han NN, Gao X, Allen MD, Levchenko A, Signaling diversity of PKA achieved via a Ca2+-cAMP-PKA oscillatory circuit. Nat Chem Biol. 2011;7:34–40.
   PubMedGoogle Scholar
• Kim JW, Roberts CD, Berg SA, Caicedo A, Roper SD, Chaudhari N. Imaging cyclic AMP changes in pancreatic islets of transgenic reporter mice. PLoS One. 2008;3:e2127.
   Google Scholar
• Davis B, Lazarus NR. Insulin release from mouse islets. Effect of glucose and hormones on adenylate cyclase. Biochem J. 1972;129:373–9.
   PubMedGoogle Scholar
• Takahashi N, Kadowaki T, Yazaki Y, Ellis-Davies GC, Miyashita Y, Kasai H. Post-priming actions of ATP on Ca2+-dependent exocytosis in pancreatic beta cells. Proc Natl Acad Sci USA. 1999;96:760–5.
   PubMed Web of Science ®Google Scholar
• Gembal M, Detimary P, Gilon P, Gao ZY, Henquin JC. Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive K+ channels in mouse B cells. J Clin Invest. 1993;91:871–80.
   Web of Science ®Google Scholar
• Yajima H, Komatsu M, Schermerhorn T, Aizawa T, Kaneko T, Nagai M, cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes. 1999;48:1006–12.
   PubMedGoogle Scholar
• Sato Y, Henquin JC. The K+-ATP channel-independent pathway of regulation of insulin secretion by glucose: in search of the underlying mechanism. Diabetes. 1998;47:1713–21.
   PubMedGoogle Scholar
• Shibasaki T, Takahashi H, Miki T, Sunaga Y, Matsumura K, Yamanaka M, Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci USA. 2007;104:19333–8.
   PubMed Web of Science ®Google Scholar
• Jones PM, Persaud SJ. Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic β-cells. Endocr Rev. 1998;19:429–61.
   PubMed Web of Science ®Google Scholar
• Lester LB, Langeberg LK, Scott JD. Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. Proc Natl Acad Sci USA. 1997;94:14942–7.
   PubMedGoogle Scholar
• Lester LB, Faux MC, Nauert JB, Scott JD. Targeted protein kinase A and PP-2B regulate insulin secretion through reversible phosphorylation. Endocrinology. 2001;142:1218–27.
   PubMedGoogle Scholar
• Fraser ID, Tavalin SJ, Lester LB, Langeberg LK, Westphal AM, Dean RA, A novel lipid-anchored A-kinase anchoring protein facilitates cAMP-responsive membrane events. EMBO J. 1998;17:2261–72.
   PubMed Web of Science ®Google Scholar
• Josefsen K, Lee YC, Thams P, Efendic S, Nielsen JH. AKAP 18 α and γ have opposing effects on insulin release in INS-1E cells. FEBS Lett. 2010;584:81–5.
   PubMedGoogle Scholar
• Faruque OM, Le-Nguyen D, Lajoix AD, Vives E, Petit P, Bataille D, Cell-permeable peptide-based disruption of endogenous PKA-AKAP complexes: a tool for studying the molecular roles of AKAP-mediated PKA subcellular anchoring. Am J Physiol Cell Physiol. 2009;296:C306–16.
   Google Scholar
• Dyachok O, Sågetorp J, Isakov Y, Tengholm A. cAMP oscillations restrict protein kinase A redistribution in insulin-secreting cells. Biochem Soc Trans. 2006;34:498–501.
   PubMedGoogle Scholar
• Gylfe E, Hellman B. Calcium and pancreatic β-cell function: modification of 45Ca fluxes by methylxanthines and dibutyryl cyclic-AMP. Biochem Med. 1981;26:365–76.
   PubMedGoogle Scholar
• Henquin JC, Meissner HP. The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin. Endocrinology. 1984;115:1125–34.
   PubMed Web of Science ®Google Scholar
• Eddlestone GT, Oldham SB, Lipson LG, Premdas FH, Beigelman PM. Electrical activity, cAMP concentration, and insulin release in mouse islets of Langerhans. Am J Physiol. 1985;248:C145–53.
   Google Scholar
• Prentki M, Glennon MC, Geschwind JF, Matschinsky FM, Corkey BE. Cyclic AMP raises cytosolic Ca2+ and promotes Ca2+ influx in a clonal pancreatic β-cell line (HIT T-15). FEBS Lett. 1987;220:103–7.
   PubMedGoogle Scholar
• Prentki M, Matschinsky FM. Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev. 1987;67:1185–248.
   PubMed Web of Science ®Google Scholar
• Grapengiesser E, Gylfe E, Hellman B. Three types of cytoplasmic Ca2+ oscillations in stimulated pancreatic β-cells. Arch Biochem Biophys. 1989;268:404–7.
   PubMed Web of Science ®Google Scholar
• Liu YJ, Grapengiesser E, Gylfe E, Hellman B. Crosstalk between the cAMP and inositol trisphosphate-signalling pathways in pancreatic β-cells. Arch Biochem Biophys. 1996;334:295–302.
   PubMed Web of Science ®Google Scholar
• Ämmälä C, Ashcroft FM, Rorsman P. Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells. Nature. 1993;363:356–8.
   PubMed Web of Science ®Google Scholar
• Kanno T, Suga S, Wu J, Kimura M, Wakui M. Intracellular cAMP potentiates voltage-dependent activation of L-type Ca2+ channels in rat islet β-cells. Pflügers Arch. 1998;435:578–80.
   PubMedGoogle Scholar
• Gromada J, Ma X, Hoy M, Bokvist K, Salehi A, Berggren PO, ATP-sensitive K+ channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1-/- mouse α-cells. Diabetes. 2004;53:S181–9.
   PubMed Web of Science ®Google Scholar
• Dyachok O, Gylfe E. Ca2+-induced Ca2+ release via inositol 1,4,5-trisphosphate receptors is amplified by protein kinase A and triggers exocytosis in pancreatic β-cells. J Biol Chem. 2004;279:45455–61.
   PubMed Web of Science ®Google Scholar
• Kim BJ, Park KH, Yim CY, Takasawa S, Okamoto H, Im MJ, Generation of nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose by glucagon-like peptide-1 evokes Ca2+ signal that is essential for insulin secretion in mouse pancreatic islets. Diabetes. 2008;57:868–78.
   PubMed Web of Science ®Google Scholar
• Kang G, Chepurny OG, Rindler MJ, Collis L, Chepurny Z, Li WH, A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic β cells. J Physiol. 2005;566:173–88.
   PubMed Web of Science ®Google Scholar
• Jones PM, Fyles JM, Howell SL. Regulation of insulin secretion by cAMP in rat islets of Langerhans permeabilised by high-voltage discharge. FEBS Lett. 1986;205:205–9.
   PubMedGoogle Scholar
• Gillis KD, Misler S. Enhancers of cytosolic cAMP augment depolarization-induced exocytosis from pancreatic B-cells: evidence for effects distal to Ca2+ entry. Pflugers Arch. 1993;424:195–7.
   PubMedGoogle Scholar
• Tamagawa T, Niki H, Niki A. Insulin release independent of a rise in cytosolic free Ca2+ by forskolin and phorbol ester. FEBS Lett. 1985;183:430–2.
   PubMedGoogle Scholar
• Skelin M, Rupnik M. cAMP increases the sensitivity of exocytosis to Ca2+ primarily through protein kinase A in mouse pancreatic beta cells. Cell Calcium. 2011;49:89–99.
   PubMedGoogle Scholar
• Hisatomi M, Hidaka H, Niki I. Ca2+/calmodulin and cyclic 3,5' adenosine monophosphate control movement of secretory granules through protein phosphorylation/dephosphorylation in the pancreatic β-cell. Endocrinology. 1996;137:4644–9.
   PubMedGoogle Scholar
• Renström E, Eliasson L, Rorsman P. Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells. J Physiol. 1997;502:105–18.
   PubMed Web of Science ®Google Scholar
• Eliasson L, Ma X, Renström E, Barg S, Berggren PO, Galvanovskis J, SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic B-cells. J Gen Physiol. 2003;121:181–97.
   PubMed Web of Science ®Google Scholar
• Wan QF, Dong Y, Yang H, Lou X, Ding J, Xu T. Protein kinase activation increases insulin secretion by sensitizing the secretory machinery to Ca2+. J Gen Physiol. 2004;124:653–62.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gillis KD. A highly Ca2+-sensitive pool of granules is regulated by glucose and protein kinases in insulin-secreting INS-1 cells. J Gen Physiol. 2004;124:641–51.
   PubMed Web of Science ®Google Scholar
• Persaud SJ, Jones PM, Howell SL. Glucose-stimulated insulin secretion is not dependent on activation of protein kinase A. Biochem Biophys Res Commun. 1990;173:833–9.
   PubMedGoogle Scholar
• Harris TE, Persaud SJ, Jones PM. Pseudosubstrate inhibition of cyclic AMP-dependent protein kinase in intact pancreatic islets: effects on cyclic AMP-dependent and glucose-dependent insulin secretion. Biochem Biophys Res Commun. 1997;232:648–51.
   PubMedGoogle Scholar
• Hatakeyama H, Kishimoto T, Nemoto T, Kasai H, Takahashi N. Rapid glucose sensing by protein kinase A for insulin exocytosis in mouse pancreatic islets. J Physiol. 2006;570:271–82.
   PubMed Web of Science ®Google Scholar
• Idevall-Hagren O, Barg S, Gylfe E, Tengholm A. cAMP mediators of pulsatile insulin secretion from glucose-stimulated single β-cells. J Biol Chem. 2010;285:23007–18.
   PubMed Web of Science ®Google Scholar
• Kanno T, Suga S, Wu J, Kimura M, Wakui M. Intracellular cAMP potentiates voltage-dependent activation of L-type Ca2+ channels in rat islet β-cells. Pflügers Arch. 1998;435:578–80.
   PubMedGoogle Scholar
• Beguin P, Nagashima K, Nishimura M, Gonoi T, Seino S. PKA-mediated phosphorylation of the human KATP channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation. EMBO J. 1999;18:4722–32.
   PubMed Web of Science ®Google Scholar
• Lin YF, Jan YN, Jan LY. Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells. EMBO J. 2000;19:942–55.
   PubMedGoogle Scholar
• Light PE, Manning Fox JE, Riedel MJ, Wheeler MB. Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism. Mol Endocrinol. 2002;16:2135–44.
   Google Scholar
• Gromada J, Brock B, Schmitz O, Rorsman P. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential. Basic Clin Pharmacol Toxicol. 2004;95:252–62.
   PubMed Web of Science ®Google Scholar
• Ozaki N, Shibasaki T, Kashima Y, Miki T, Takahashi K, Ueno H, cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol. 2000;2:805–11.
   PubMed Web of Science ®Google Scholar
• Holz GG, Kang G, Harbeck M, Roe MW, Chepurny OG. Cell physiology of cAMP sensor Epac. J Physiol. 2006;577:5–15.
   PubMed Web of Science ®Google Scholar
• Leech CA, Chepurny OG, Holz GG. Epac2-dependent rap1 activation and the control of islet insulin secretion by glucagon-like peptide-1. Vitam Horm. 2010;84:279–302.
   PubMed Web of Science ®Google Scholar
• Holz GG. Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic β-cell. Diabetes. 2004;53:5–13.
   PubMed Web of Science ®Google Scholar
• Leech CA, Holz GG, Chepurny O, Habener JF. Expression of cAMP-regulated guanine nucleotide exchange factors in pancreatic β-cells. Biochem Biophys Res Commun. 2000;278:44–7.
   PubMedGoogle Scholar
• Kelley GG, Chepurny OG, Schwede F, Genieser HG, Leech CA, Roe MW, Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM. Islets. 2009;1:260–5.
   PubMed Web of Science ®Google Scholar
• Chepurny OG, Kelley GG, Dzhura I, Leech CA, Roe MW, Dzhura E, PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM in human islets of Langerhans. Am J Physiol Endocrinol Metab. 2010;298:E622–33.
   PubMed Web of Science ®Google Scholar
• Niimura M, Miki T, Shibasaki T, Fujimoto W, Iwanaga T, Seino S. Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function. J Cell Physiol. 2009;219:652–8.
   PubMedGoogle Scholar
• Chepurny OG, Leech CA, Kelley GG, Dzhura I, Dzhura E, Li X, Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: studies with 8-pCPT-2'-O-Me-cAMP-AM. J Biol Chem. 2009;284:10728–36.
   PubMed Web of Science ®Google Scholar
• Kwan EP, Gao X, Leung YM, Gaisano HY. Activation of exchange protein directly activated by cyclic adenosine monophosphate and protein kinase A regulate common and distinct steps in promoting plasma membrane exocytic and granule-to-granule fusions in rat islet beta cells. Pancreas. 2007;35:e45–54.
   Google Scholar
• Wang Z, Thurmond DC. Mechanisms of biphasic insulin-granule exocytosis—roles of the cytoskeleton, small GTPases and SNARE proteins. J Cell Sci. 2009;122:893–903.
   PubMed Web of Science ®Google Scholar
• Kowluru A. Small G proteins in islet b-cell function. Endocr Rev. 2010;31:52–78.
   PubMed Web of Science ®Google Scholar
• Dzhura I, Chepurny OG, Kelley GG, Leech CA, Roe MW, Dzhura E, Epac2-dependent mobilization of intracellular Ca2+ by GLP-1 receptor agonist Exendin-4 is disrupted in β-cells of PLC-ϵ knockout mice. J Physiol. 2010;588:4871–89.
   PubMed Web of Science ®Google Scholar
• Dzhura I, Chepurny OG, Leech CA, Roe MW, Dzhura E, Xu X, Phospholipase C-ϵ links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans. Islets. 2011;3:121–8.
   PubMed Web of Science ®Google Scholar
• Kang G, Chepurny OG, Holz GG. cAMP-regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+-induced Ca2+ release in INS-1 pancreatic β-cells. J Physiol. 2001;536:375–85.
   PubMed Web of Science ®Google Scholar
• Kang G, Joseph JW, Chepurny OG, Monaco M, Wheeler MB, Bos JL, Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic β-cells. J Biol Chem. 2003;278:8279–85.
   PubMed Web of Science ®Google Scholar
• Kang G, Leech CA, Chepurny OG, Coetzee WA, Holz GG. Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic β-cells and rat INS-1 cells. J Physiol. 2008;586:1307–19.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Shibasaki T, Minami K, Takahashi H, Mizoguchi A, Uriu Y, Rim2α determines docking and priming states in insulin granule exocytosis. Cell Metab. 2010;12:117–29.
   PubMedGoogle Scholar
• Kashima Y, Miki T, Shibasaki T, Ozaki N, Miyazaki M, Yano H, Critical role of cAMP-GEFII–Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem. 2001;276:46046–53.
   PubMed Web of Science ®Google Scholar
• Fujimoto K, Shibasaki T, Yokoi N, Kashima Y, Matsumoto M, Sasaki T, Piccolo, a Ca2+ sensor in pancreatic beta-cells. Involvement of cAMP-GEFII.Rim2.Piccolo complex in cAMP-dependent exocytosis. J Biol Chem. 2002;277:50497–502.
   PubMed Web of Science ®Google Scholar
• Shibasaki T, Sunaga Y, Fujimoto K, Kashima Y, Seino S. Interaction of ATP sensor, cAMP sensor, Ca2+ sensor, and voltage-dependent Ca2+ channel in insulin granule exocytosis. J Biol Chem. 2004;279:7956–61.
   PubMed Web of Science ®Google Scholar
• Vikman J, Svensson H, Huang YC, Kang Y, Andersson SA, Gaisano HY, Truncation of SNAP-25 reduces the stimulatory action of cAMP on rapid exocytosis in insulin-secreting cells. Am J Physiol Endocrinol Metab. 2009;297:E452–61.
   Web of Science ®Google Scholar
• Zhang CL, Katoh M, Shibasaki T, Minami K, Sunaga Y, Takahashi H, The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science. 2009;325:607–10.
   PubMed Web of Science ®Google Scholar
• Hatakeyama H, Takahashi N, Kishimoto T, Nemoto T, Kasai H. Two cAMP-dependent pathways differentially regulate exocytosis of large dense-core and small vesicles in mouse β-cells. J Physiol. 2007;582:1087–98.
   PubMed Web of Science ®Google Scholar
• Herbst KJ, Coltharp C, Amzel LM, Zhang J. Direct activation of Epac by sulfonylurea is isoform selective. Chem Biol. 2011;18:243–51.
   PubMedGoogle Scholar
• Tsalkova T, Gribenko AV, Cheng X. Exchange protein directly activated by cyclic AMP isoform 2 is not a direct target of sulfonylurea drugs. Assay Drug Dev Technol. 2011;9:88–91.
   PubMedGoogle Scholar
• Rehmann H. Epac2: a sulfonylurea receptor? Biochem Soc Trans. 2012;40:6–10.
   PubMedGoogle Scholar
• Brooker G, Fichman M. Chlorpropamide and tolbutamide inhibition of adenosine 3'5' cyclic monophosphate phosphodiesterase. Biochem Biophys Res Commun. 1971;42:824–8.
   PubMedGoogle Scholar
• Goldfine ID, Perlman R, Roth J. Inhibition of cyclic 3',5'-AMP phosphodiesterase in islet cells and other tissues by tolbutamide. Nature. 1971;234:295–7.
   PubMedGoogle Scholar
• Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC. Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of glicazide therapy. Metabolism. 1989;38:767–72.
   PubMed Web of Science ®Google Scholar
• Lang DA, Matthews DR, Burnett M, Turner RC. Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes. 1981;30:435–9.
   Google Scholar
• Mari A, Tura A, Natali A, Laville M, Laakso M, Gabriel R, Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia. 2010;53:749–56.
   PubMedGoogle Scholar
• Kahn SE, Zraika S, Utzschneider KM, Hull RL. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia. 2009;52:1003–12.
   PubMed Web of Science ®Google Scholar
• Nauck M, Stockmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia. 1986;29:46–52.
   PubMed Web of Science ®Google Scholar
• Unger RH. Glucagon physiology and pathophysiology in the light of new advances. Diabetologia. 1985;28:574–8.
   PubMed Web of Science ®Google Scholar
• Rosengren AH, Jokubka R, Tojjar D, Granhall C, Hansson O, Li DQ, Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science. 2010;327:217–20.
   PubMed Web of Science ®Google Scholar
• Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010;42:142–8.
   Google Scholar
• Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42:105–16.
   PubMed Web of Science ®Google Scholar
• Rabinovitch A, Renold AE, Cerasi E. Decreased cyclic AMP and insulin responses to glucose in pancreatic islets of diabetic Chinese hamsters. Diabetologia. 1976;12:581–7.
   PubMedGoogle Scholar
• Dachicourt N, Serradas P, Giroix MH, Gangnerau MN, Portha B. Decreased glucose-induced cAMP and insulin release in islets of diabetic rats: reversal by IBMX, glucagon, GIP. Am J Physiol. 1996;271:E725–32.
   Google Scholar
• Dolz M, Movassat J, Bailbe D, Le Stunff H, Giroix MH, Fradet M, cAMP-secretion coupling is impaired in diabetic GK/Par rat beta-cells: a defect counteracted by GLP-1. Am J Physiol Endocrinol Metab. 2011;301:E797–806.
   PubMedGoogle Scholar
• Abdel-Halim SM, Guenifi A, Khan A, Larsson O, Berggren PO, Östenson CG, Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Diabetes. 1996;45:934–40.
   PubMedGoogle Scholar
• Abdel-Halim SM, Guenifi A, He B, Yang B, Mustafa M, Hojeberg B, Mutations in the promoter of adenylyl cyclase (AC)-III gene, overexpression of AC-III mRNA, and enhanced cAMP generation in islets from the spontaneously diabetic GK rat model of type 2 diabetes. Diabetes. 1998;47:498–504.
   PubMedGoogle Scholar
• Frayon S, Pessah M, Giroix MH, Mercan D, Boissard C, Malaisse WJ, Gαolf identification by RT-PCR in purified normal pancreatic B cells and in islets from rat models of non-insulin-dependent diabetes. Biochem Biophys Res Commun. 1999;254:269–72.
   PubMedGoogle Scholar
• Portela-Gomes GM, Abdel-Halim SM. Overexpression of Gs proteins and adenylyl cyclase in normal and diabetic islets. Pancreas. 2002;25:176–81.
   PubMedGoogle Scholar
• Dubois M, Vacher P, Roger B, Huyghe D, Vandewalle B, Kerr-Conte J, Glucotoxicity inhibits late steps of insulin exocytosis. Endocrinology. 2007;148:1605–14.
   PubMed Web of Science ®Google Scholar
• Furman B, Pyne N, Flatt P, O'Harte F. Targeting β-cell cyclic 3'5' adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review. J Pharm Pharmacol. 2004;56:1477–92.
   PubMed Web of Science ®Google Scholar
• Thompson PE, Manganiello V, Degerman E. Re-discovering PDE3 inhibitors—new opportunities for a long neglected target. Curr Top Med Chem. 2007;7:421–36.
   PubMed Web of Science ®Google Scholar
• Ahrén B. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov. 2009;8:369–85.
   PubMed Web of Science ®Google Scholar
• Lovshin JA, Drucker DJ. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5:262–9.
   PubMed Web of Science ®Google Scholar
• Knop FK, Vilsboll T, Holst JJ. Incretin-based therapy of type 2 diabetes mellitus. Curr Protein Pept Sci. 2009;10:46–55.
   PubMedGoogle Scholar
• Ohishi T, Yoshida S. The therapeutic potential of GPR119 agonists for type 2 diabetes. Expert Opin Investig Drugs. 2012;21:321–8.
   PubMed Web of Science ®Google Scholar